Sector | Trading | Compare with Sector peers |
Industry | Trading | Compare with Industry peers |
Website | http://www.welcuredrugs.com | |
Market Cap | 6.55 Cr. | |
Enterprise Value(EV) | 6.24 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 0.01 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 595.76 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 64.26 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 1.06 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 4.58 | Calculated using Price: 4.85 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 1.35 Cr. | 13,512,100 Shares |
FaceValue | 10 | |
About Welcure Drugs & Pharmaceuticals Ltd. | ||
Welcure Drugs & Pharmaceuticals Ltd. (WDPL) was incorporated as a Public Limited Company under the Companies Act, 1956 on 4th June, 1992 and obtained the certificate of commencement of business on 19th June 1992. |
1 Day |
|
+4.98% |
1 Week |
|
+2.97% |
1 Month |
|
+21.55% |
3 Month |
|
+10.23% |
6 Month |
|
+25.97% |
1 Year |
|
+24.36% |
2 Year |
|
-45.87% |
5 Year |
|
+931.91% |
10 Year |
|
+380.20% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 0 | 0 | 108.61 | -65.8 | 17.83 | -49.46 | 131.74 | 29.03 | 12.65 | |
Return on Capital Employed (%) | 0 | 0 | 108.91 | -65.46 | 18.22 | -48.94 | 131.94 | 29.12 | 12.67 | |
Return on Assets (%) | 10.4 | 227.41 | 94.5 | -58.62 | 14.57 | -34.54 | 112.99 | 27.77 | 12.51 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 1 | |
Non Curr. Liab. | |||||||||||
Curr. Liab. | 0 | 0 | 0 | 0 | 0 | ||||||
Minority Int. | |||||||||||
Equity & Liab. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 1 | |
Non Curr. Assets | 0 | 2 | 1 | ||||||||
Curr. Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 1 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Other Income | 0 | 0 | 0 | ||||||||
Total Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Total Expenditure | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
PBIDT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Interest | |||||||||||
Depreciation | 0 | ||||||||||
Taxation | |||||||||||
Exceptional Items | |||||||||||
PAT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Adjusted EPS | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
Cash Fr. Inv. | 0 | 0 | 1 | ||||||||
Cash Fr. Finan. | -1 | ||||||||||
Net Change | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Fri, 19 Apr 2024
Submission Of Certificate Under Regulation 40 (9) Of SEBI (Listing Obligation And Disclosure Requirement) Regulations 2015 For The Year Ended 31Stmarch 2024 Compliance of Regulation 40 (9) of SEBI (LODR) Regulation 2015 |
Sat, 13 Apr 2024
Compliance Certificate For The Period March 2024 Compliance Certificate under Regulation 7(3) |
Fri, 12 Apr 2024
Submission Of Disclosure Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Compliance regarding Regulation 32 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 |
Mon, 22 Apr 2024 |
High Delivery Percentage |
Opening at Low |
Closing Above Previous High |
High Increase in 1 Month |
High Increase in 6 Months |